Noninvasive ultrasound assessment of bladder function

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the effectiveness of a new noninvasive ultrasound method called Quantitative Ultrasound Bladder Vibrometry (QUBV) for assessing detrusor overactivity and aiding in treatment selection for benign prostatic hyperplasia (BPH). Participants will undergo QUBV ultrasound concurrently with a urodynamic study as part of their routine clinical care. The goal is to determine if this innovative approach can reliably detect abnormal bladder function.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Aim1:

Age \>18 scheduled to undergo UDS for their clinical care for one of the included diagnoses.

-Aim2: Inclusions: Age \>45 scheduled to undergo selective photovaporization of the prostate.

Exclusion Criteria:

* Aim1:Obesity (BMI \>35kg/m2), known neurologic disease impacting bladder function (e.g. spinal cord injury, multiple sclerosis, Parkinson's, prior cerebrovascular accident), previous pelvic radiation therapy, previous radical pelvic surgery (such as for uterine or colorectal cancer), prior bladder surgery (including prostate resection), and pregnant or breast-feeding women.
* Aim2:Obesity (BMI \>35kg/m2), known neurologic disease impacting bladder function (e.g. spinal cord injury, multiple sclerosis, Parkinson's, prior cerebrovascular accident), previous pelvic radiation therapy, previous radical pelvic surgery (such as colorectal cancer).

Where it's running

• Mayo Clinic
  Rochester, Minnesota, United States Recruiting

Study contacts

• Principal investigator: Azra Alizad, MD — Mayo Clinic
• Study coordinator: Azra Alizad, MD
• Email: alizad.azra@mayo.edu
• Phone: 5075381727

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Flyte device to help urinary incontinence after pelvic radiation for endometrial or cervical cancer

  This study tests whether a home-use Flyte device, used during guided pelvic floor exercises, can improve urinary incontinence in women who had pelvic radiation for endometrial or cervical cancer.

  Recruiting Mayo Clinic · Rochester, Minnesota · NCT07662824

• Self-Start Macrobid for post-Botox lower urinary symptoms

  This study tests whether giving a standing prescription for Macrobid after Botox treatment reduces urgent calls, messages, and visits for urinary symptoms compared with usual triage care.

  Recruiting Early Phase 1 The Cleveland Clinic · Cleveland, Ohio · NCT07648290

• How time on dialysis and urine output affect bladder size and flexibility in people waiting for a kidney transplant

  See if longer time on dialysis and lower urine output make the bladder smaller and less flexible in adults with end-stage kidney disease who are awaiting a transplant.

  Recruiting Sindh Institute of Urology and Transplantation · Karachi, Sindh · NCT07570771

• ZIDA Control Sock added to medication for overactive bladder with leakage

  This trial will try using the ZIDA Control Sock once a week at home for 12 weeks to see if adding it to your current medication reduces urgency urinary incontinence.

  Recruiting Medical University of South Carolina · Charleston, South Carolina · NCT07432659

• Vaginal radiofrequency treatment targeting bladder nerves for overactive bladder in women

  This trial will test whether a single vaginal radiofrequency treatment with the MORPHEUSV device can reduce urgency-related urine leaks in adult women with overactive bladder.

  Recruiting at 5 sites InMode MD Ltd. · Palo Alto, California and 8 other locations · NCT07209397

• Tensi+ European registry for overactive bladder

  This registry will collect information on adults with overactive bladder who use the Tensi+ posterior tibial nerve stimulation device to see if it helps symptoms and is safe over one year.

  Recruiting at 12 sites Stimuli Technology · Bron and 16 other locations · NCT07205445

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.